keyword
https://read.qxmd.com/read/38304092/selected-advances-in-the-anti-arrhythmic-management-of-atrial-fibrillation-2023
#21
JOURNAL ARTICLE
James A Reiffel
No abstract text is available yet for this article.
January 2024: Journal of Innovations in Cardiac Rhythm Management
https://read.qxmd.com/read/38296548/a-novel-strategy-for-the-discovery-of-drug-targets-integrating-clinical-evidence-with-molecular-studies
#22
JOURNAL ARTICLE
Shuji Kaneko
The mechanisms of several drugs remain unclear, limiting our understanding of how they exert their effects. Receptor affinities have not been comprehensively measured during drug development, and the safety investigations in humans are limited. Therefore, numerous unknown adverse and beneficial effects of drugs in humans persist. In this review, I highlight our achievements in identifying the unexpected beneficial effects of drugs through the analysis of real-world clinical data, which can contribute to drug repositioning and target finding...
2024: Biological & Pharmaceutical Bulletin
https://read.qxmd.com/read/38275179/vallesamidine-and-schizozygane-alkaloids-rearranged-monoterpene-indole-alkaloids-and-synthetic-endeavours
#23
REVIEW
Xiangyu Zhang
Covering 1963 to 2023Monoterpene indole alkaloids are the main sub-family of indole alkaloids with fascinating structures, stereochemistry, and diverse bioactivities ( e.g. , anticancer, anti-malarial and anti-arrhythmic etc. ). Vallesamidine alkaloids and structurally more complex schizozygane alkaloids are small groups of rearranged monoterpene indole alkaloids with a unique 2,2,3-trialkylated indoline scaffold, while schizozygane alkaloids can generate a further rearranged skeleton, isoschizozygane, possessing a tetra-substituted, bridged tetrahydroquinoline core...
January 26, 2024: Natural Product Reports
https://read.qxmd.com/read/38253398/ent-verticilide-b1-inhibits-type-2-ryanodine-receptor-channels-and-is-antiarrhythmic-in-casq2-mice
#24
JOURNAL ARTICLE
Aaron Gochman, Tri Q Do, Kyungsoo Kim, Jacob A Schwarz, Madelaine P Thorpe, Daniel J Blackwell, Paxton Ritschel, Abigail N Smith, Robyn T Rebbeck, Wendell S Akers, Razvan L Cornea, Derek R Laver, Jeffrey N Johnston, Bjorn C Knollmann
Ca2+ leak from cardiac ryanodine receptor (RyR2) is an established mechanism of sudden cardiac death (SCD), whereby dysregulated Ca2+ handling causes ventricular arrhythmias. We previously discovered the RyR2-selective inhibitor ent-(+)-verticilide (ent-1), a 24-membered cyclooligomeric depsipeptide that is the enantiomeric form of a natural product (nat-(-)-verticilide). Here, we examined its 18-membered ring-size oligomer (ent-verticilide B1; ent-B1) in single RyR2 channel assays, [3H]ryanodine binding assays, and in Casq2-/- cardiomyocytes and mice, a gene-targeted model of SCD...
January 22, 2024: Molecular Pharmacology
https://read.qxmd.com/read/38204277/amiodarone-advances-the-apoptosis-of-cardiomyocytes-by-repressing-sigmar1-expression-and-blocking-kcnh2-related-potassium-channels
#25
JOURNAL ARTICLE
Huiqing Liang, Huixian Li, Fangjiang Li, Xiaobo Xiong, Yang Gao
BACKGROUND: Heart failure (HF) is the ultimate transformation result of various cardiovascular diseases. Mitochondria-mediated cardiomyocyte apoptosis has been uncovered to be associated with this disorder. OBJECTIVE: This study mainly delves into the mechanism of the anti-arrhythmic drug amiodarone on mitochondrial toxicity of cardiomyocytes. METHODS: The viability of H9c2 cells treated with amiodarone at 0.5, 1, 2, 3, and 4 μM was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and Sigmar1 expression was examined by quantitative real-time PCR (qRTPCR)...
January 8, 2024: Current Molecular Medicine
https://read.qxmd.com/read/38198753/cardiac-mao-a-inhibition-protects-against-catecholamine-induced-ventricular-arrhythmias-via-enhanced-diastolic-calcium-control
#26
JOURNAL ARTICLE
Qian Shi, Hamza Malik, Rachel M Crawford, Jennifer Streeter, Jinxi Wang, Ran Huo, Jean C Shih, Biyi Chen, Duane Hall, E Dale Abel, Long-Sheng Song, Ethan J Anderson
AIMS: A mechanistic link between depression and risk of arrhythmias could be attributed to altered catecholamine metabolism in the heart. Monoamine oxidase-A (MAO-A), a key enzyme involved in catecholamine metabolism and longstanding antidepressant target, is highly expressed in the myocardium. The present study aimed to elucidate the functional significance and underlying mechanisms of cardiac MAO-A in arrhythmogenesis. METHODS AND RESULTS: Analysis of TriNetX database revealed that depressed patients treated with MAO inhibitors had a lower risk of arrhythmias compared to those treated with selective serotonin reuptake inhibitors...
January 10, 2024: Cardiovascular Research
https://read.qxmd.com/read/38185911/differential-effects-of-mechano-electric-feedback-mechanisms-on-whole-heart-activation-repolarization-and-tension
#27
JOURNAL ARTICLE
Tobias Gerach, Axel Loewe
The human heart is subject to highly variable amounts of strain during day-to-day activities and needs to adapt to a wide range of physiological demands. This adaptation is driven by an autoregulatory loop that includes both electrical and the mechanical components. In particular, mechanical forces are known to feed back into the cardiac electrophysiology system, which can result in pro- and anti-arrhythmic effects. Despite the widespread use of computational modelling and simulation for cardiac electrophysiology research, the majority of in silico experiments ignore this mechano-electric feedback entirely due to the high computational cost associated with solving cardiac mechanics...
January 7, 2024: Journal of Physiology
https://read.qxmd.com/read/38146256/oral-anti-coagulants-use-in-chinese-hospitalized-patients-with-atrial-fibrillation
#28
JOURNAL ARTICLE
Jing Lin, Deyong Long, Chenxi Jiang, Caihua Sang, Ribo Tang, Songnan Li, Wei Wang, Xueyuan Guo, Man Ning, Zhaoqing Sun, Na Yang, Yongchen Hao, Jun Liu, Jing Liu, Xin Du, Louise Morgan, Gregg C Fonarow, Sidney C Smith, Gregory Y H Lip, Dong Zhao, Jianzeng Dong, Changsheng Ma
BACKGROUND: Oral anti-coagulants (OAC) are the intervention for the prevention of stroke, which consistently improve clinical outcomes and survival among patients with atrial fibrillation (AF). The main purpose of this study is to identify problems in OAC utilization among hospitalized patients with AF in China. METHODS: Using data from the Improving Care for Cardiovascular Disease in China-Atrial Fibrillation (CCC-AF) registry, guideline-recommended OAC use in eligible patients was assessed...
December 22, 2023: Chinese Medical Journal
https://read.qxmd.com/read/38139404/altering-calcium-sensitivity-in-heart-failure-a-crossroads-of-disease-etiology-and-therapeutic-innovation
#29
REVIEW
Nancy S Saad, Mohammed A Mashali, Steven J Repas, Paul M L Janssen
Heart failure (HF) presents a significant clinical challenge, with current treatments mainly easing symptoms without stopping disease progression. The targeting of calcium (Ca2+ ) regulation is emerging as a key area for innovative HF treatments that could significantly alter disease outcomes and enhance cardiac function. In this review, we aim to explore the implications of altered Ca2+ sensitivity, a key determinant of cardiac muscle force, in HF, including its roles during systole and diastole and its association with different HF types-HF with preserved and reduced ejection fraction (HFpEF and HFrEF, respectively)...
December 17, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/38130027/wound-incidence-and-outcomes-in-atrial-fibrillation-comparing-catheter-ablation-and-anti-arrhythmic-drug-therapy
#30
JOURNAL ARTICLE
Zhou Xinyu, Xia Sheng
The most prevalent form of cardiac arrhythmia is atrial fibrillation (AF), which is typically managed through catheter ablation or anti-arrhythmic drug therapy. We compared the incidence and outcomes of wound complications in patients with atrial fibrillation who were treated with catheter ablation as opposed to anti-arrhythmic drug therapy. From May to November 2023, 240 adult AF patients who were treated with catheter ablation or anti-arrhythmic medications participated in a 6-month retrospective cohort study at Sir Run Run Shaw Hospital in Hangzhou, China...
December 21, 2023: International Wound Journal
https://read.qxmd.com/read/38105572/ivabradine-for-congenital-ectopic-tachycardia-in-newborn
#31
JOURNAL ARTICLE
Ozge Pamukcu, Rümeysa Citli
INTRODUCTION: Congenital junctional ectopic tachycardia is a rare arrhythmia that occurs in patients without previous cardiac surgery. In this report, we wanted to present a 6-hour-old newborn with congenital junctional ectopic tachycardia resistant to conventional anti-arrhythmic medications, who was successfully treated with ivabradine and amiadarone combination. CASE: A six-hour-old newborn girl was hospitalised in neonatal ICU because transient tachypnoea of the newborn...
February 2024: Cardiology in the Young
https://read.qxmd.com/read/38093391/jak2-as-a-surface-marker-for-enrichment-of-human-pluripotent-stem-cells-derived-ventricular-cardiomyocytes
#32
JOURNAL ARTICLE
Lee Chuen Liew, Boon Min Poh, Omer An, Beatrice Xuan Ho, Christina Ying Yan Lim, Jeremy Kah Sheng Pang, Leslie Y Beh, Henry He Yang, Boon-Seng Soh
BACKGROUND: Human pluripotent stem cell (hPSC)-derived cardiomyocytes (CMs) hold great promise for cardiac disease modelling, drug discovery and regenerative medicine. Despite the advancement in various differentiation protocols, the heterogeneity of the generated population composed of diverse cardiac subtypes poses a significant challenge to their practical applications. Mixed populations of cardiac subtypes can compromise disease modelling and drug discovery, while transplanting them may lead to undesired arrhythmias as they may not integrate and synchronize with the host tissue's contractility...
December 13, 2023: Stem Cell Research & Therapy
https://read.qxmd.com/read/38081511/lncrna-ccrr-attenuates-post-myocardial-infarction-inflammatory-response-by-inhibiting-the-tlr-signaling-pathway
#33
JOURNAL ARTICLE
Shengjie Wang, Lina Xuan, Xiaolin Hu, Feihan Sun, Siyun Li, Xiufang Li, Hua Yang, Jianjun Guo, Xiaomeng Duan, Huishan Luo, Jieru Xin, Jun Chen, Junwei Hao, Shijia Cui, Dongping Liu, Lei Jiao, Ying Zhang, Zhimin Du, Lihua Sun
BACKGROUND: Timely and proper suppression of inflammation can effectively reduce myocardial injury and promote post-myocardial infarction (post-MI) wound healing process. We have previously found that cardiac conduction regulatory RNA (CCRR), a long noncoding RNA (lncRNA) transcribed by the gene located on chromosome 9 with abundant expression in the heart, elicits anti-arrhythmic effects in heart failure, and this is a continuing study on the role of CCRR in MI. METHODS: CCRR was overexpressed in CCRR transgenic mice or after injection of adeno-associated virus-9 (AAV-9)...
December 9, 2023: Canadian Journal of Cardiology
https://read.qxmd.com/read/38066422/rediscover-the-predictive-capacity-of-b-type-natriuretic-peptide-applied-to-neonatal-supraventricular-tachycardia
#34
JOURNAL ARTICLE
Yaheng Lu, Ying Xiong, Yizhou Wen, Yanfeng Yang, Hanmin Liu
BACKGROUND: Supraventricular tachycardia (SVT) is one of the most common non-benign arrhythmias in neonates, potentially leading to cardiac decompensation. This study investigated the early risk factors of acute heart failure (AHF) secondary to SVT in neonates, and explored their value in guiding the selection of effective anti-arrhythmic treatment. METHODS: A total of 43 newborns diagnosed with and treated for SVT between January 2017 and December 2022 were analyzed...
December 8, 2023: BMC Cardiovascular Disorders
https://read.qxmd.com/read/38048669/low-intensity-pulsed-ultrasound-treatment-mitigates-ventricular-arrhythmias-via-inhibiting-microglia-mediated-neuroinflammation-in-heart-failure-rat-model
#35
JOURNAL ARTICLE
Hongjie Yang, Yugang Hu, Bin Kong, Yanxiang Zhou, Wei Shuai
BACKGROUND: Sympathetic overactivation plays an important role in heart failure (HF)-induced ventricular arrhythmias (VAs). Microglia-mediated neuroinflammation could contribute to sympathetic overactivation. A previous study demonstrated that low-intensity pulsed ultrasound (LIPUS) could inhibit neuroinflammation. However, whether LIPUS could attenuate HF-induced VAs via inhibiting microglia-mediated neuroinflammation remains largely unknown. METHODS: Forth Sprague-Dawley male rats were averagely randomized into four groups: CTL (control) group, CTL + LIPUS group, HF group and HF + LIPUS...
December 2, 2023: International Immunopharmacology
https://read.qxmd.com/read/38042505/nardostachys-jatamansi-phytochemistry-ethnomedicinal-uses-and-pharmacological-activities-a-comprehensive-review
#36
REVIEW
Shilpi Pathak, Ramreddy Godela
A member of the Valerianacae family, Nardostachys jatamansi is the smallest, most primitive, perennial, dwarf, hairy, rhizomatous, herbaceous species. It has an enlarged antiquity of usage as ayurvedic medicine, homeopathic medicine, ethnomedicine, and the Indian system of medicine, and is now used in the modern medicine industry. In the ayurvedic medical system, the rhizomes of the plant are used as a bitter tonic, stimulant, antispasmodic, epileptic treatment, and for hysteria. Pharmacological reports on Nardostachys jatamansi revealed its antifungal activity, hepatoprotective activity, central nervous system activity, anticonvulsant activity, neuroprotective activity, antiparkinson's activity, antioxidant activity, antidiabetic activity, tranquilizing activity, antiestrogenic activity furthermore, Jatamansone has also been linked to anti-hypertensive, anti-arrhythmic, anti-asthmatic, nematicidal, and antibacterial effects...
November 30, 2023: Fitoterapia
https://read.qxmd.com/read/38040503/dapansutrile-ameliorates-atrial-inflammation-and-vulnerability-to-atrial-fibrillation-in-hfpef-rats
#37
JOURNAL ARTICLE
Hongjie Yang, Jun Zhu, Hui Fu, Wei Shuai
BACKGROUND: Numerous studies have demonstrated that NLRP3 inflammasomes are key players in the progression of atrial fibrillation (AF) in heart failure with preserved ejection fraction (HFpEF). This study aimed to analyse the effect of pharmacological inhibition of NLRP3 inflammasomes using dapansutrile (DAPA), an oral NLRP3-specific inhibitor. METHODS: Dahl salt-sensitive rats were fed a high-salt diet (HSD, 8% NaCl) to induce HFpEF. Either DAPA (200 mg/kg/day) or saline was administered daily via gavage for 4 weeks...
November 30, 2023: Heart, Lung & Circulation
https://read.qxmd.com/read/38024821/insights-on-the-mechanism-of-flecainide-in-catecholaminergic-polymorphic-ventricular-tachycardia
#38
JOURNAL ARTICLE
Ross Davidson, Maria Medeiros
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia syndrome characterized by defective cardiac ryanodine receptor (RyR2) calcium release during times of adrenergic stimulation, resulting in bidirectional or polymorphic ventricular tachycardia. Flecainide is a class 1c anti-arrhythmic drug that has demonstrated therapeutic efficacy in treating CPVT. However, its mechanism of action remains disputed. One group proposes a direct effect of flecainide on RyR2-mediated calcium release, while another proposes an indirect effect via sodium channel blockade and modulation of intracellular calcium dynamics...
August 2023: Journal of Medicine and Life
https://read.qxmd.com/read/38017033/the-treatment-with-trandolapril-and-losartan-attenuates-pressure-and-volume-overload-alternations-of-cardiac-connexin-43-and-extracellular-matrix-in-ren-2-transgenic-rats
#39
JOURNAL ARTICLE
Matus Sykora, Vojtech Kratky, Ludek Cervenka, Libor Kopkan, Narcis Tribulova, Barbara Szeiffova Bacova
Heart failure (HF) is life-threatening disease due to electro-mechanical dysfunction associated with hemodynamic overload, while alterations of extracellular matrix (ECM) along with perturbed connexin-43 (Cx43) might be key factors involved. We aimed to explore a dual impact of pressure, and volume overload due to aorto-caval fistula (ACF) on Cx43 and ECM as well as effect of renin-angiotensin blockade. Hypertensive Ren-2 transgenic rats (TGR) and normotensive Hannover Sprague-Dawley rats (HSD) that underwent ACF were treated for 15-weeks with trandolapril or losartan...
November 27, 2023: Scientific Reports
https://read.qxmd.com/read/37986405/anthracyclines-and-the-risk-of-arrhythmias-a-systematic-review-and-meta-analysis
#40
JOURNAL ARTICLE
Yomna E Dean, Hazem Dahshan, Karam R Motawea, Ziad Khalifa, Yousef Tanas, Ibrahim Rakha, Walaa Hasan, Mohamed Kishk, Alaa Mahmoud, Ahmed Elsayed, Omar Abdelkader, Akiko Tokunaga, Ahmed Khalifa, Ahmed Helmy, Rowan H Elhalag, Raghad Moheyeldin Farghaly, Omar Khalid Samir Abdelkader, Jaffer Shah, Diaa Hakim, Hani Aiash
BACKGROUND: There have been controversial findings from recent studies regarding anthracyclines use and the subsequent risk of arrhythmias. This study aimed to evaluate the existing evidence of the risk of arrhythmias in patients treated with anthracyclines. METHODS: PubMed, Scopus, and Web of Science databases were searched up to April 2022 using keywords such as "anthracycline" and "arrhythmia." Dichotomous data were presented as relative risk (RR) and confidence interval (CI), while continuous data were presented as mean difference (MD) and CI...
November 17, 2023: Medicine (Baltimore)
keyword
keyword
1030
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.